Takeda takes its Zika vaccine candidate into clinical testing – The Pharma Letter
12/01/2017
The Pharma LetterTakeda takes its Zika vaccine candidate into clinical testingThe Pharma LetterTokyo's Takeda Pharmaceutical (TSE: 4502) is progressing its Zika vaccine candidate TAK-426 into Phase I trials, backed by funding from the US Department of Health and Human Services (HSS), the company has announced. A trial involving 240 male and …
12/01/2017
The Pharma LetterTakeda takes its Zika vaccine candidate into clinical testingThe Pharma LetterTokyo's Takeda Pharmaceutical (TSE: 4502) is progressing its Zika vaccine candidate TAK-426 into Phase I trials, backed by funding from the US Department of Health and Human Services (HSS), the company has announced. A trial involving 240 male and …
Zika Virus Persists in Tears of Convalescence Patients – Infectious Disease Advisor
12/01/2017
Zika Virus Persists in Tears of Convalescence PatientsInfectious Disease AdvisorThe presence of Zika virus RNA in human tears 30 days post-illness was shown in patients with polymerase chain reaction (PCR)-confirmed Zika virus infection, according to results published in Nature Scientific Reports. The outbreak of Zika virus …
12/01/2017
Zika Virus Persists in Tears of Convalescence PatientsInfectious Disease AdvisorThe presence of Zika virus RNA in human tears 30 days post-illness was shown in patients with polymerase chain reaction (PCR)-confirmed Zika virus infection, according to results published in Nature Scientific Reports. The outbreak of Zika virus …
Takeda Pharma begins phase 1 trial of Zika vaccine candidate, TAK-426
12/01/2017
Takeda Pharma begins phase 1 trial of Zika vaccine candidate, TAK-426pharmabiz.comIn recent years, the Zika virus has had a devastating impact, spreading across more than 84 countries, territories or subnational areas, including the US, In February 2016, the World Health Organization (WHO) declared the Zika outbreak to be a Public …
12/01/2017
Takeda Pharma begins phase 1 trial of Zika vaccine candidate, TAK-426pharmabiz.comIn recent years, the Zika virus has had a devastating impact, spreading across more than 84 countries, territories or subnational areas, including the US, In February 2016, the World Health Organization (WHO) declared the Zika outbreak to be a Public …
Zika contract worth up to $4.9 million awarded to Chembio – Virgin Islands Daily News
12/01/2017
Zika contract worth up to $4.9 million awarded to ChembioVirgin Islands Daily NewsA manufacturer from Medford, N.Y., has won a contract worth up to $4.9 million to supply a Zika diagnostic test and companion results reader to UNICEF. Chembio Diagnostics Inc. said the United Nations International Children's Emergency Fund has agreed …
12/01/2017
Zika contract worth up to $4.9 million awarded to ChembioVirgin Islands Daily NewsA manufacturer from Medford, N.Y., has won a contract worth up to $4.9 million to supply a Zika diagnostic test and companion results reader to UNICEF. Chembio Diagnostics Inc. said the United Nations International Children's Emergency Fund has agreed …
CNS infections: Zika virus mutation associated with increased infectivity, mortality and severe microcephaly
12/01/2017
CNS infections: Zika virus mutation associated with increased infectivity, mortality and severe microcephalyNature.comNew research suggests that a Ser138Asp substitution in prM, a structural protein of Zika virus, contributed to the 2013 outbreak of the virus in French Polynesia. Researchers found that strains of the virus isolated in 2015–2016 caused higher mortality …
12/01/2017
CNS infections: Zika virus mutation associated with increased infectivity, mortality and severe microcephalyNature.comNew research suggests that a Ser138Asp substitution in prM, a structural protein of Zika virus, contributed to the 2013 outbreak of the virus in French Polynesia. Researchers found that strains of the virus isolated in 2015–2016 caused higher mortality …